Teva Pharmaceutical Industries

NYSE: TEVA
$13.19
-$0.12 (-0.9%)
Closing price February 21, 2020

Why Teva’s Grand Turnaround Could Just Be Getting Started

Posted: February 18, 2020 at 1:15 pm

It seems to have been a long time since there were all that many positive statements about Teva Pharmaceutical Industries Ltd. (NYSE: TEVA). But a look through the slew of ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Arconic, CenturyLink, eHealth, Nvidia, Salesforce, Tesla, Teva and More

Posted: February 18, 2020 at 9:10 am
Last updated: February 19, 2020 8:15 am

Stocks were close to all-time highs last Friday ahead of the three-day weekend, despite the coronavirus news getting worse, but the news from Apple has sent the stock indexes lower ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Applied Materials, Cisco, Cognizant, Costco, Enphase, Medtronic, Shopify, Starbucks, Teva, Xilinx and More

Posted: February 13, 2020 at 9:00 am

Stocks have risen and risen, with all three major U.S. indexes hitting new highs, but profit-taking and more coronavirus news dominated the headlines on Thursday morning. Many investors have yet ...
Read Full Story »

Cisco, CVS, Lyft, Nvidia, Shopify, Roku and More Major Earnings Coming This Week

Posted: February 9, 2020 at 7:05 am

The fourth-quarter earnings reporting season has reached a peak, but many more major companies will be sharing their results soon. With the coronavirus, China and impeachment dominating the news flow, ...
Read Full Story »

Will Teva Stock Collapse Before It Fixes Its Problems?

Posted: January 28, 2020 at 11:15 am

Teva Pharmaceuticals Industries Ltd. (NASDAQ: TEVA), the generic drug company, was founded in 1901 in Israel. It has become one of the largest pharmaceutical companies in the world. Teva recently ...
Read Full Story »

Short Sellers Can’t Make Up Their Mind on Big Pharma

Posted: January 28, 2020 at 9:35 am
Last updated: January 30, 2020 10:37 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Shy Away From Big Pharma

Posted: January 13, 2020 at 9:40 am
Last updated: January 30, 2020 11:19 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Big Pharma Short Sellers Get Selective

Posted: December 26, 2019 at 8:55 am
Last updated: January 30, 2020 11:48 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Big Pharma Short Sellers Grow More Selective

Posted: December 11, 2019 at 9:45 am
Last updated: January 30, 2020 12:18 pm

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Big Pharma Short Sellers Hike Their Bets

Posted: November 27, 2019 at 9:00 am
Last updated: January 30, 2020 12:42 pm

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Posted: November 12, 2019 at 9:15 am
Last updated: January 30, 2020 1:18 pm

Stocks were mixed in the premarket on Tuesday and the day was just looking for direction after last week's all-time highs. Investors still have a lot of pressing issues and ...
Read Full Story »

Big Pharma Scares Off Short Sellers

Posted: November 12, 2019 at 8:50 am
Last updated: January 30, 2020 1:18 pm

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Big Pharma

Posted: October 25, 2019 at 9:59 am
Last updated: January 30, 2020 2:06 pm

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Big Pharma Sees Rising Tide in Short Interest

Posted: October 10, 2019 at 9:40 am
Last updated: January 30, 2020 2:48 pm

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Unusual Settlement Deal Proposed for Opioid Lawsuits

Posted: October 1, 2019 at 12:00 pm
Last updated: January 30, 2020 3:11 pm

Five pharmaceuticals makers are proposing an unusual method for settling hundreds of the more than 2,500 lawsuits facing drugmakers that made and sold opioid painkillers. The five companies want to ...
Read Full Story »